Global Neoantigen Targeted Therapies Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Monotherapy
  • 1.4.3 Combination Therapy
• 1.5 Market by Application
  • 1.5.1 Global Neoantigen Targeted Therapies Market Share by Application (2019-2025)
  • 1.5.2 Medical Research Institution
  • 1.5.3 Hospital and Clinic
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Neoantigen Targeted Therapies Market Size
• 2.2 Neoantigen Targeted Therapies Growth Trends by Regions
  • 2.2.1 Neoantigen Targeted Therapies Market Size by Regions (2019-2025)
  • 2.2.2 Neoantigen Targeted Therapies Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Neoantigen Targeted Therapies Market Size by by Players
  • 3.1.1 Global Neoantigen Targeted Therapies Revenue by by Players (2014-2019)
  • 3.1.2 Global Neoantigen Targeted Therapies Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Neoantigen Targeted Therapies Market Concentration Ratio (CR5 and HHI)
• 3.2 Neoantigen Targeted Therapies Key Players Head office and Area Served
• 3.3 Key Players Neoantigen Targeted Therapies Product/Solution/Service
• 3.4 Date of Enter into Neoantigen Targeted Therapies Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Neoantigen Targeted Therapies Market Size by Type (2014-2019)
• 4.2 Global Neoantigen Targeted Therapies Market Size by Application (2014-2019)

5 North America

• 5.1 North America Neoantigen Targeted Therapies Market Size (2014-2019)
• 5.2 Neoantigen Targeted Therapies Key Players in North America
• 5.3 North America Neoantigen Targeted Therapies Market Size by Type
• 5.4 North America Neoantigen Targeted Therapies Market Size by Application

6 Europe

• 6.1 Europe Neoantigen Targeted Therapies Market Size (2014-2019)
• 6.2 Neoantigen Targeted Therapies Key Players in Europe
• 6.3 Europe Neoantigen Targeted Therapies Market Size by Type
• 6.4 Europe Neoantigen Targeted Therapies Market Size by Application

7 China

• 7.1 China Neoantigen Targeted Therapies Market Size (2014-2019)
• 7.2 Neoantigen Targeted Therapies Key Players in China
• 7.3 China Neoantigen Targeted Therapies Market Size by Type
• 7.4 China Neoantigen Targeted Therapies Market Size by Application

8 Japan

• 8.1 Japan Neoantigen Targeted Therapies Market Size (2014-2019)
• 8.2 Neoantigen Targeted Therapies Key Players in Japan
• 8.3 Japan Neoantigen Targeted Therapies Market Size by Type
• 8.4 Japan Neoantigen Targeted Therapies Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Neoantigen Targeted Therapies Market Size (2014-2019)
• 9.2 Neoantigen Targeted Therapies Key Players in Southeast Asia
• 9.3 Southeast Asia Neoantigen Targeted Therapies Market Size by Type
• 9.4 Southeast Asia Neoantigen Targeted Therapies Market Size by Application

10 India

• 10.1 India Neoantigen Targeted Therapies Market Size (2014-2019)
• 10.2 Neoantigen Targeted Therapies Key Players in India
• 10.3 India Neoantigen Targeted Therapies Market Size by Type
• 10.4 India Neoantigen Targeted Therapies Market Size by Application

11 Central & South America

• 11.1 Central & South America Neoantigen Targeted Therapies Market Size (2014-2019)
• 11.2 Neoantigen Targeted Therapies Key Players in Central & South America
• 11.3 Central & South America Neoantigen Targeted Therapies Market Size by Type
• 11.4 Central & South America Neoantigen Targeted Therapies Market Size by Application

12 International Players Profiles

• 12.1 Bavarian Nordic
  • 12.1.1 Bavarian Nordic Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Neoantigen Targeted Therapies Introduction
  • 12.1.4 Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2014-2019))
  • 12.1.5 Bavarian Nordic Recent Development
• 12.2 Genocea Biosciences
  • 12.2.1 Genocea Biosciences Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Neoantigen Targeted Therapies Introduction
  • 12.2.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2014-2019)
  • 12.2.5 Genocea Biosciences Recent Development
• 12.3 Gradalis
  • 12.3.1 Gradalis Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Neoantigen Targeted Therapies Introduction
  • 12.3.4 Gradalis Revenue in Neoantigen Targeted Therapies Business (2014-2019)
  • 12.3.5 Gradalis Recent Development
• 12.4 Immunicum
  • 12.4.1 Immunicum Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Neoantigen Targeted Therapies Introduction
  • 12.4.4 Immunicum Revenue in Neoantigen Targeted Therapies Business (2014-2019)
  • 12.4.5 Immunicum Recent Development
• 12.5 Immunovative Therapies
  • 12.5.1 Immunovative Therapies Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Neoantigen Targeted Therapies Introduction
  • 12.5.4 Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2014-2019)
  • 12.5.5 Immunovative Therapies Recent Development
• 12.6 Iovance Biotherapeutics
  • 12.6.1 Iovance Biotherapeutics Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Neoantigen Targeted Therapies Introduction
  • 12.6.4 Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2014-2019)
  • 12.6.5 Iovance Biotherapeutics Recent Development
• 12.7 MediGene
  • 12.7.1 MediGene Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Neoantigen Targeted Therapies Introduction
  • 12.7.4 MediGene Revenue in Neoantigen Targeted Therapies Business (2014-2019)
  • 12.7.5 MediGene Recent Development
• 12.8 Neon Therapeutics
  • 12.8.1 Neon Therapeutics Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Neoantigen Targeted Therapies Introduction
  • 12.8.4 Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2014-2019)
  • 12.8.5 Neon Therapeutics Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer